←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Immunotherapy, Lung Cancer
Julio Sosa
MD
🏢Hospital Universitario 12 de Octubre🌐Spain
Thoracic Medical Oncologist
22
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Julio Sosa participates in Spanish Lung Cancer Group neoadjuvant studies in resectable NSCLC, including chemo-immunotherapy platforms. His work supports pathologic response and ctDNA based endpoint development. He is based in Madrid.
Share:
🧪Research Fields 研究领域
NSCLC clinical trials
neoadjuvant chemo-IO
biomarker analysis
Spanish Lung Cancer Group
early stage disease
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Julio Sosa 的研究动态
Follow Julio Sosa's research updates
留下邮箱，当我们发布与 Julio Sosa（Hospital Universitario 12 de Octubre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment